Mereo BioPharma Group PLC (MREO)

4.095 +0.08 (+2.12%) USD  |  NASDAQ  |  Nov 05, 16:00
4.095 0.00 (0.00%) After-Hours: 16:24
More

Mereo BioPharma Group EPS Estimates for Current Quarter

EPS Estimates for Current Quarter Chart

View EPS Estimates for Current Quarter for MREO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical EPS Estimates for Current Quarter Data

View and export this data back to 2024. Upgrade now.
Date Value
August 13, 2024 --
June 21, 2024 --
Date Value
June 12, 2024 --
May 16, 2024 --

Earnings Per Share Estimates Definition

This is the earnings consensus estimate for a given period of time, according to analysts polled by Standard & Poor's.

Read full definition.

EPS Estimates for Current Quarter Range, Past 5 Years

Upgrade
Minimum
Aug 13 2024
Upgrade
Maximum
Jun 21 2024
Upgrade
Average
Upgrade
Median

EPS Estimates for Current Quarter Benchmarks

NuCana PLC Upgrade
TC BioPharm (Holdings) PLC --
Adaptimmune Therapeutics PLC Upgrade
Biodexa Pharmaceuticals PLC --
Bicycle Therapeutics PLC Upgrade

EPS Estimates for Current Quarter Related Metrics

Revenue Estimates for Next Quarter Upgrade
Revenue Estimates for Current Fiscal Year Upgrade
Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade